Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IceCure Medical (ICCM) Gross Margin (2020 - 2025)

Historic Gross Margin for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to 32.59%.

  • IceCure Medical's Gross Margin fell 29100.0% to 32.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 35.06%, marking a year-over-year decrease of 86100.0%. This contributed to the annual value of 44.09% for FY2024, which is 38300.0% up from last year.
  • Per IceCure Medical's latest filing, its Gross Margin stood at 32.59% for Q3 2025, which was down 29100.0% from 24.95% recorded in Q2 2025.
  • IceCure Medical's 5-year Gross Margin high stood at 65.39% for Q1 2021, and its period low was 7.03% during Q3 2023.
  • In the last 5 years, IceCure Medical's Gross Margin had a median value of 45.34% in 2023 and averaged 40.9%.
  • As far as peak fluctuations go, IceCure Medical's Gross Margin crashed by -332200bps in 2023, and later skyrocketed by 425300bps in 2024.
  • IceCure Medical's Gross Margin (Quarter) stood at 46.46% in 2021, then grew by 6bps to 49.09% in 2022, then decreased by -8bps to 45.34% in 2023, then rose by 5bps to 47.66% in 2024, then plummeted by -32bps to 32.59% in 2025.
  • Its last three reported values are 32.59% in Q3 2025, 24.95% for Q2 2025, and 30.07% during Q1 2025.